Cargando…

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

BACKGROUND: Multidisciplinary attempts to understand the etiology of breast cancer are expanding to increasingly include new potential markers of disease risk. Those efforts may have maximal scientific and practical influence if new findings are placed in context of the well-understood lifestyle and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacey, James V, Kreimer, Aimee R, Buys, Saundra S, Marcus, Pamela M, Chang, Shih-Chen, Leitzmann, Michael F, Hoover, Robert N, Prorok, Philip C, Berg, Christine D, Hartge, Patricia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670317/ https://www.ncbi.nlm.nih.gov/pubmed/19292893 http://dx.doi.org/10.1186/1471-2407-9-84

Ejemplares similares

Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies
por: Pfeiffer, Ruth M., et al.
Publicado: (2013)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Wentzensen, Nicolas, et al.
Publicado: (2011)

Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
por: Xu, Xin
Publicado: (2020)

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing
por: Greenberg, Samantha, et al.
Publicado: (2019)

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
por: Wegwarth, Odette, et al.
Publicado: (2018)

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
por: Zheng, Rui, et al.
Publicado: (2018)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial
por: He, Shisi, et al.
Publicado: (2022)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

Ovarian cancer, ovulation and side of origin.
por: Hartge, P., et al.
Publicado: (1995)

Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort
por: Orloff, Mohammed S., et al.
Publicado: (2012)

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022)

Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
por: Chien, Li-Hsin, et al.
Publicado: (2022)

Association between soft drink consumption types and risk of lung cancer and all-cancer: A prospective study of PLCO data
por: You, Dongfang, et al.
Publicado: (2022)

Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial
por: Guertin, Kristin A., et al.
Publicado: (2015)

Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial
por: Luo, Linna, et al.
Publicado: (2020)

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort
por: Reichard, Chad A., et al.
Publicado: (2022)

Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry
por: Ferris, J S, et al.
Publicado: (2014)

Prospective study of physical activity and risk of postmenopausal breast cancer
por: Leitzmann, Michael F, et al.
Publicado: (2008)

Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma
por: Mai, Phuong L., et al.
Publicado: (2009)

Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
por: Piccolo, Stephen R., et al.
Publicado: (2015)

Prognosis according to the timing of recurrence in breast cancer
por: Lee, Young Joo, et al.
Publicado: (2023)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Publicado: (2015)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Body Fat Distribution and Risk of Breast, Endometrial, and Ovarian Cancer: A Two-Sample Mendelian Randomization Study
por: Freuer, Dennis, et al.
Publicado: (2021)

Familial Breast and Ovarian Cancer
por: Spence, R A J
Publicado: (2003)

The genetics of breast and ovarian cancer.
por: Ford, D., et al.
Publicado: (1995)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

HRness in Breast and Ovarian Cancers
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2020)

Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information
por: Himes, Deborah O., et al.
Publicado: (2015)

Breast cancer prognosis in relation to family history of breast and ovarian cancer
por: Thalib, L, et al.
Publicado: (2004)

Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
por: Houghton, Lauren C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hm6agd9t151dgd8905cp51f2k4